- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07711535
Development of Context-Adapted Quality Indicators for Early Sepsis Care in Sub-Saharan Africa - A Modified Delphi Consensus Procedure
Study Overview
Status
Conditions
Detailed Description
The expert panel will be recruited through purposive sampling via existing national and international sepsis networks (including the Sub-Saharan African Consortium for the Advancement of Innovative Research and Care in Africa, "STAIRS"), scientific collaborations, and personal invitations from the study team in Berlin.
Invited are professionals with proven experience in sepsis care or sepsis research in sub-Saharan Africa, including physicians, nurses, researchers, and other healthcare professionals involved in acute care and quality assurance.
For the first Delphi round, the investigators plan to recruit approximately 10-15 experts. In a second recruitment phase, participants may nominate additional experts with relevant expertise (snowball sampling). The total number of panel members should not exceed 30-45.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Claudia Spies, MD, Prof.
- Phone Number: +49 30 450 55 11 02
- Email: claudia.spies@charite.de
Study Locations
-
-
-
Kumasi, Ghana
- Recruiting
- The Komfo Anokye teaching hospital
-
Contact:
- Phone Number: +233 593 830 400
- Email: info@kath.gov.gh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Professionals with proven experience in sepsis care or sepsis research in low- and middle-income countries, particularly Sub-Saharan Africa including physicians, nurses, researchers, and other healthcare professionals involved in early acute care and quality assurance
- Minimum age of 18
- Willingness to voluntarily participate in one or more Delphi rounds
Exclusion criteria:
- Lack of professional expertise in the field of sepsis care
- Refusal to consent to participation
- Withdrawal from participation at the participant's own request
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The degree of expert consensus on individual quality indicators
Time Frame: Up to October 2026
|
The degree of expert consensus on individual quality indicators, measured on a 5-point Likert scale (median and interquartile range) .
|
Up to October 2026
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The final, agreed-upon set of quality indicators
Time Frame: Up to October 2026
|
The final, agreed-upon set of quality indicators is developed during the project
|
Up to October 2026
|
|
The agreed-upon structure of the STEPS survey instrument.
Time Frame: Up to October 2026
|
The agreed-upon structure of the STEPS survey instrument.
|
Up to October 2026
|
|
The agreed-upon content of the STEPS survey instrument.
Time Frame: Up to October 2026
|
The agreed-upon content of the STEPS survey instrument.
|
Up to October 2026
|
Collaborators and Investigators
Investigators
- Study Director: Claudia Spies, MD, Prof., Charite University, Berlin, Germany
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Delphi-QI-Steps
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.